title: Lack of muscle toxicity with didanosine (ddI). Clinical and experimental studies.
abstract: Currently, 2',3'-dideoxyinosine (ddI) is used in AIDS therapy. To investigate the possible myotoxicity of ddI in patients infected with human immunodeficiency virus (HIV), we examined the effect of ddI in vitro in tissue cultures of skeletal muscles of rats exposed to ddI at doses equivalent to plasma ddI levels obtained in the treatment of HIV patients. Control cultures were exposed to normal saline and zidovudine (AZT). After 4 weeks no changes were noted in the ddI and normal saline cultures, but AZT cultures showed abnormal accumulation of mitochondria. The creatine kinase values in culture supernatants were all normal. We also reviewed the clinical, nutritional and biological parameters, AZT and ddI dosage, and histochemical findings in muscle specimens of 14 HIV patients receiving ddI therapy. All patients had previously received AZT. The mean cumulative dose of ddI was 91.6 gm. Two patients had myalgia, 9 muscle atrophy, and 13 weakness. All patients were malnourished. Five patients had mitochondrial myopathy related to AZT, 4 had ddI-associated neuropathy and 2 patients had only selective type 2 fiber atrophy. One patient had necrotizing vasculitis, one had scattered necrotic fibers and type 2 fiber atrophy and 2 had a normal muscle biopsy. On the basis of the results, we have been unable to implicate ddI as a cause of skeletal myopathy.
authors.affiliation: Department of Internal Medicine, Hospital Clínic, University of Barcelona, Spain.
authors.forename: E
authors.initials: E
authors.lastname: Pedrol
authors.forename: F
authors.initials: F
authors.lastname: Masanés
authors.forename: J
authors.initials: J
authors.lastname: Fernández-Solá
authors.forename: M
authors.initials: M
authors.lastname: Cofan
authors.forename: J
authors.initials: J
authors.lastname: Casademont
authors.forename: J M
authors.initials: JM
authors.lastname: Grau
authors.forename: A
authors.initials: A
authors.lastname: Urbano-Márquez
mesh_terms: D000328:Adult; D000818:Animals; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000633:toxicity; D001706:Biopsy; D002478:Cells, Cultured; D016049:Didanosine / Q000009:adverse effects* / Q000633:toxicity; D015658:HIV Infections / Q000188:drug therapy / Q000473:pathology; D006801:Humans; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000166:cytology / Q000187:drug effects*; D051381:Rats; D017208:Rats, Wistar; D012189:Retrospective Studies
chemical_list: D019380:Anti-HIV Agents; D016049:Didanosine